COVID Vaccination in DMT-Treated MS Patients: New Data

COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies.
Medscape Medical News

Leave a Reply

Your email address will not be published.